Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database.

Maria Maddalena NicolettiErminia CrisciVincenzo CosenzaConsiglia RiccardiMaria Rosaria CampitielloDonatella RuggieroPasquale Maria BerrinoGiovanni DocimoCristina Scavone

Published in: Drugs - real world outcomes (2023)

Considering the seriousness of ICI-induced scleroderma cases and the recent marketing authorization of some ICIs, we believe that further high-quality clinical studies should be conducted on this topic to better estimate the impact of these events in patients with cancer.

Keyphrases

systemic sclerosis
adverse drug
interstitial lung disease
drug induced
electronic health record
diabetic rats
big data
emergency department
oxidative stress
idiopathic pulmonary fibrosis